• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Explainable Machine Learning Reveals Challenges in Predicting Parkinson’s Motor Complications

by
November 16, 2026
in Health
Reading Time: 2 mins read
0
Explainable Machine Learning Reveals Challenges in Predicting Parkinson’s Motor Complications

Explainable Machine Learning Reveals Challenges in Predicting Parkinson’s Motor Complications

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A new study applying explainable machine learning to real-world, multicentric clinical data from 247 patients with Parkinson’s disease highlights the significant challenges inherent in forecasting the onset of motor complications. The research focused on predicting the development of levodopa-induced dyskinesias and motor fluctuations over a three-year period. By employing a transparent prognostic framework, researchers sought to establish a more reliable approach to risk stratification for patients currently free of these specific complications.

The performance evaluation of the predictive models yielded moderate results, with a Matthews correlation coefficient (MCC) of 0.28 for levodopa-induced dyskinesias and 0.32 for motor fluctuations. To assess the interpretability of these models, the team utilized SHAP-based techniques. This analysis confirmed that the model predictions were consistent with established clinical knowledge, identifying levodopa duration and the total Levodopa Equivalent Daily Dose as the primary drivers of risk. Specifically, the data indicated that the risk for new-onset complications increases significantly when the dosage surpasses a threshold of 300–400 mg.

A critical component of the study involved an ablation test, which underscored the necessity of including diverse clinical presentations in training datasets. When researchers excluded patients who already suffered from pre-existing complications from the training process, the model’s sensitivity collapsed. This finding demonstrates that access to the full spectrum of disease severity is essential for developing robust risk stratification tools, as focusing solely on patients who have yet to develop complications appears to limit the model’s predictive utility.

The methodological stress-test conducted by the research team ultimately reveals that reliance on baseline clinical features alone results in limited absolute sensitivity. These findings emphasize that while machine learning can provide insight into risk factors, the complexity of Parkinson’s disease trajectory requires more than static baseline data. The authors suggest that integrating dynamic, longitudinal patient information is a necessary evolution to achieve the level of clinical-grade individualized prediction required for optimizing long-term disease management.

Subject of Research: Prognostic machine learning models for motor complications in Parkinson's disease

Article Title: Explainable machine learning reveals the challenges of predicting new-onset motor complications in Parkinson’s disease

Article References: Endrizzi, W., Campese, N., Ragni, F., Moroni, M., Bovo, S., Longo, C., Gios, L., Uccelli, A., Giometto, B., Jurman, G., Osmani, V., Malaguti, M. C., the NeuroArtP3 Network, Falini, A., Castellano, A., Rossi, A., Tortora, D., Parodi, C., Verrico, A., … Bacchin, R. (2026). Explainable machine learning reveals the challenges of predicting new-onset motor complications in Parkinson’s disease. npj Parkinson's Disease. https://doi.org/10.1038/s41531-026-01550-1

Image Credits: AI Generated

DOI: 10.1038/s41531-026-01550-1

Keywords: Parkinson’s disease, machine learning, explainable AI, motor complications, levodopa, dyskinesia, prognostic modeling, clinical data, real-world evidence, risk stratification, neurodegenerative disorders, predictive analytics, SHAP, levodopa equivalent daily dose, clinical decision support

News Source: Diana Fleming. (November 16, 2026). Explainable Machine Learning Reveals Challenges in Predicting Parkinson’s Motor Complications. Scienmag.

Tags: clinical dataClinical decision supportdyskinesiaExplainable AIlevodopalevodopa equivalent daily doseMachine Learningmotor complicationsneurodegenerative disordersParkinson’s diseasepredictive analyticsprognostic modelingReal-world evidencerisk stratificationSHAP
Share12Tweet7Share2ShareShareShare1

Related Posts

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

November 17, 2026
Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer's and Parkinson's

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

November 17, 2026

Posterior Cruciate Ligament Continuously Lengthens Across Knee Flexion in Healthy Adults

November 17, 2026

3D-Printed Guide Template Associated With Improved Spinal Deformity Correction in Cohort

November 17, 2026

POPULAR NEWS

  • Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    Review Highlights Multi-Level Factors Influencing Clinical AI Adoption by Healthcare Providers

    29 shares
    Share 12 Tweet 7
  • Gut Microbiota and Metabolites Influence Immunotherapy Response in Liver Cancer

    29 shares
    Share 12 Tweet 7
  • Nonlinear Sex-Specific Remodeling of the TCRβ Repertoire During Adult Aging

    29 shares
    Share 12 Tweet 7
  • Capped Nanovials Enable Extended Cell Growth and Screening in UCLA Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Fusobacterium nucleatum Extracellular Vesicles Trigger Neuroinflammation and Anxiety-Like Behaviors via IL-1β

Experiential Workshop Expands Mexican Students’ Understanding of Bat Diets and Ecological Roles

Immune Cell Exhaustion May Drive Neurodegeneration in Alzheimer’s and Parkinson’s

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.